:

 
Cancer Center Clinical Trials
Medical Oncology

Seeking Patients with Asymptomatic Smoldering Multiple Myeloma for Lenalidomide Test Trial
Official Title:ECOG 3A06: Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic Smoldering Multiple Myeloma
Date Window: 11/21/2012 - 11/21/2017
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:To test how well lenalidomide works to treat asymptomatic smoldering multiple

ClinicalTrials.gov identifier
NCT01169337


Official Title:ECOG 2906: Phase III Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnos
Date Window: 11/26/2012 - 11/26/2017
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:
To compare the effectiveness of clofarabine to standard induction chemotherapy, and to test the effectiveness of decitabine as maintenance therapy, in patients over age 60 with acute myelogenous leukemia.

ClinicalTrials.gov identifier
NCT01041703


Contact

Location
Building 17B
3rd Floor, Suite E

Phone
Main (301) 295-8239/8219

Hours of Operation
Monday thru Friday
0700 - 1630